HIV-1 drug resistance in primary infections in the UK.

HIV-1 drug resistance in primary infections in the UK.

Bibliographic Details
Main Authors:	Fidler, S, Frater, J, Clarke, J, Weber, J
Format:	Journal article
Language:	English
Published:	2001

Similar Items

HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial
by: Frater, A, et al.
Published: (2013)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
by: Frater, J, et al.
Published: (2019)

Simple detection of point mutations associated with HIV-1 drug resistance.
by: Frater, A, et al.
Published: (2001)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
by: Stöhr, W, et al.
Published: (2013)

Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
by: Beddows, S, et al.
Published: (2003)

Immunotherapeutic approaches to HIV cure and remission
by: Lee, MJ, et al.
Published: (2021)

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
by: Hoffmann, M, et al.
Published: (2016)

Protective HLA class I alleles are associated with reduced immune activation and fibrinolysis in individuals with primary HIV infection
by: Hamlyn, E, et al.
Published: (2010)

PP 8.11 – 00174 Distinct HIV reservoir characteristics among individuals treated during primary versus chronic HIV infection
by: C. Bittar Oliva, et al.
Published: (2022-12-01)

Advancing the HIV cure agenda: the next 5 years.
by: Thornhill, J, et al.
Published: (2015)

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
by: Yager, N, et al.
Published: (2013)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery.
by: Thornhill, J, et al.
Published: (2017)

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
by: Hamlyn, E, et al.
Published: (2012)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008)

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection
by: Thornhill, JP, et al.
Published: (2019)

Short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2013)

Modeling Drug Resistance Emergence and Transmission in HIV-1 in the UK
by: Anna Zhukova, et al.
Published: (2023-05-01)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
by: Fidler, S, et al.
Published: (2017)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
by: Martin, G, et al.
Published: (2017)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.
by: Wolfgang Stöhr, et al.
Published: (2013-01-01)

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.
by: Frater, A, et al.
Published: (2002)

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
by: Oxenius, A, et al.
Published: (2001)

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
by: Frater, A, et al.
Published: (2000)

Persistent elevation of Tim-3 and PD-1 on memory T cells despite early ART initiation during primary HIV infection
by: G.E. Martin, et al.
Published: (2019-07-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

Drug-resistant HIV increasing, UK study finds
by: Karen Birmingham

Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population
by: Panagiota Zacharopoulou, et al.
Published: (2024-03-01)

Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.
by: Joanne D Stekler, et al.
Published: (2011-01-01)

Thirty years of treating HIV-1 infection: where next?
by: Frater, A
Published: (2015)

Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
by: Matthias Hoffmann, et al.
Published: (2016-07-01)

Tuberculosis Drug Resistance and HIV Infection, the Netherlands
by: Catharina Hendrika Haar, et al.
Published: (2007-05-01)

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients.
by: Frater, A, et al.
Published: (2001)

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
by: Matthew Pace, et al.
Published: (2022-08-01)

HIV-1 Protease: Structural Perspectives on Drug Resistance
by: Irene T. Weber, et al.
Published: (2009-12-01)

The impact of HIV-1 subtype on the clinical response on HAART.
by: Frater, J
Published: (2002)

B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
by: Huang, K, et al.
Published: (2010)

Structured observations reveal slow HIV-1 CTL escape
by: Roberts, H, et al.
Published: (2015)

Primary HCV Drug Resistance Mutations in Patients with Newly Diagnosed HIV Infection
by: Yu. V. Ostankova, et al.
Published: (2020-10-01)